表纸
市场调查报告书
商品编码
366599

大肠癌诊断检验的全球市场:医疗设备的开发平台评估

Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020

出版日期: | 出版商: GlobalData | 英文 265 Pages | 订单完成后即时交付

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

  • 全貌
  • 简介
  • 目录
简介

本报告提供全球大肠癌诊断检验相关产品市场上的主要开发中产品及其临床实验的进展调查,再汇整产品功能·特性比较分析 (临床实验的各进展阶段) ,与主要企业简介及代表性产品,近来的市场动静 (业绩报告·资本交易趋势等) 资讯,为您概述为以下内容。

第1章 目录

第2章 简介

  • 大肠癌诊断检验概要

第3章 临床实验中的产品

  • 开发中产品:各临床实验阶段
  • 开发中产品:各领域
  • 开发中产品:各法规途径
  • 开发中产品:各估计认证时期
  • 开发中产品:现在进行中的临床实验

第4章 临床实验中的开发中产品:各企业

  • 大肠癌诊断检验的企业:各临床实验阶段的开发中产品
  • 大肠癌诊断检验:各临床实验阶段的开发中产品

第5章 大肠癌诊断检验市场:企业·产品概要 (全119公司份)

  • A2K Technologies
  • Abbott Diagnostics
  • Abcodia Ltd.
  • Acobiom
  • Advanced Marker Discovery, S.L.
  • Advpharma Inc.
  • Ambergen, Inc.
  • Ambrilia Biopharma Inc.
  • Arizona State University
  • ArtemixRx
  • Asuragen, Inc.
  • Bio Mark Ltd
  • Biocartis SA
  • Biodesix Inc.
  • BioMarCare Technologies Ltd.
  • BioMark Diagnostics Inc.
  • BioMarker Strategies, LLC
  • bioMerieux S.A.
  • Biomoda, Inc. (Inactive)
  • Biosceptre (Aust) Pty Ltd
  • BioSystems International
  • Biotechnostics GmbH
  • BioTime, Inc.
  • Biotron Limited
  • Castle Biosciences Incorporated
  • Cellmid Limited
  • Ceres Nanosciences, Inc.
  • Cernostics Inc.
  • China Sky One Medical, Inc.
  • Chronix Biomedical, Inc.
  • Cleveland Diagnostics Inc.
  • ColoPrev
  • Columbia University
  • Courtagen Life Sciences, Inc.
  • CS-Keys, Inc.
  • Di.V.A.L Toscana srl
  • Diadexus Inc
  • DiagnoCure Inc.
  • Diaxonhit S.A.
  • EDP Biotech Corporation
  • Epigenomics AG
  • Eventus Diagnostics, Inc.
  • Exact Sciences Corporation
  • Exiqon A/S
  • Exosomics Siena SpA
  • Fina Biotech
  • GenomicTree, Inc.
  • Ghent University
  • GlycoZym
  • Health Discovery Corporation
  • Human Metabolome Technologies, Inc.
  • Ikonisys, Inc.
  • InterGenetics Incorporated
  • IV Diagnostics, Inc.
  • John Hopkins University
  • Lab21 Limited
  • Laboratorios Alpha San Ignacio Pharma S.L.
  • Lightsphere Diagnostics
  • LX Diagnostics
  • MabCure Inc.
  • Matrix-Bio, Inc.
  • Max-Delbruck-Centrum fur Molekulare Medizin (MDC)
  • MDNA Life Sciences, Inc.
  • MDxHealth SA
  • Merrimack Pharmaceuticals, Inc.
  • Metabiomics Corporation
  • Metabolomic Technologies Inc.
  • Metabolon, Inc.
  • MetaStat, Inc.
  • Milagen, Inc.
  • Miraculins Inc.
  • Mode Dx Ltd.
  • Moscow Institute of Physics and Technology
  • Myriad Genetics, Inc.
  • Nanosphere, Inc.
  • NetScientific Plc
  • Norda ASA
  • Novel Bio-spectrum Technologies, Inc.
  • Nuclea Biotechnologies Inc.
  • Nuvera Biosciences, Inc.
  • Oncimmune (USA) LLC
  • OncoVista Innovative Therapies, Inc.
  • On-Q-ity, Inc. (Inactive)
  • Origin Sciences Limited
  • Orion Genomics LLC
  • OTraces Inc.
  • Oxford Cancer Biomarkers
  • Oxford Gene Technology Limited
  • Panacea Pharmaceuticals, Inc.
  • PleX Diagnostics
  • Precision Biologics, Inc.
  • Prediction Sciences
  • Protagen AG
  • Rabin Medical Center
  • Rosetta Genomics Ltd
  • Scienion AG
  • Seegene, Inc.
  • Shuwen Biotech Co. Ltd.
  • Siamab Therapeutics, Inc.
  • Skuldtech France
  • Sysmex
  • Tel Aviv University
  • The Chinese University of Hong Kong
  • The Walter and Eliza Hall Institute of Medical Research
  • TheraDiag SA
  • Theranostics Health, Inc.
  • Todos Medical Company Overview
  • Universal Diagnostics, S. L.
  • Universite De Lyon
  • University of Alabama at Birmingham
  • University of Illinois at Chicago
  • University of Texas at Austin
  • US Biomarkers, Inc.
  • Vanderbilt University
  • Vermillion, Inc.
  • Viomics Inc.
  • Vitatex Inc.
  • VolitionRX Ltd.
  • XEPTAGEN SpA

第6章 大肠癌诊断检验市场市场:目前的趋势 (全99件)

第7章 附录

图表一览

目录
Product Code: GDME1030EPD

GlobalData's Medical Devices sector report, "Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Colorectal Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Colorectal Cancer Diagnostic Tests are used for detection of CRC based on the detection and measurement of cancer-specific biomarker/antibody/antigen present in patient's sample.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Colorectal Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Colorectal Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Colorectal Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Colorectal Cancer Overview

3 Products under Development

  • 3.1 Colorectal Cancer - Pipeline Products by Stage of Development
  • 3.2 Colorectal Cancer - Pipeline Products by Territory
  • 3.3 Colorectal Cancer - Pipeline Products by Regulatory Path
  • 3.4 Colorectal Cancer - Pipeline Products by Estimated Approval Date
  • 3.5 Colorectal Cancer - Ongoing Clinical Trials

4 Colorectal Cancer - Pipeline Products under Development by Companies

  • 4.1 Colorectal Cancer Companies - Pipeline Products by Stage of Development
  • 4.2 Colorectal Cancer - Pipeline Products by Stage of Development

5 Colorectal Cancer Companies and Product Overview

6 Colorectal Cancer- Recent Developments 1887 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

List of Tables

  • Table 1: Colorectal Cancer - Pipeline Products by Stage of Development
  • Table 2: Colorectal Cancer - Pipeline Products by Territory
  • Table 3: Colorectal Cancer - Pipeline Products by Regulatory Path
  • Table 4: Colorectal Cancer - Pipeline Produ

List of Figures

List of Figures

  • Figure 1: Colorectal Cancer - Pipeline Products by Stage of Development
  • Figure 2: Colorectal Cancer - Pipeline Products by Territory
  • Figure 3: Colorectal Cancer - Pipeline Products by Regulatory Path
  • Figure 4: Colorectal Cancer - Pipeline